FSI
ASBPW

Flow State Investments’s Aspire Biopharma Warrant ASBPW Stock Holding History

Flow State Investments’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-113,498
Closed -$5.1K – 153
2024
Q2 		$5.1K Hold
113,498
– – ﹤0.01% 179
2024
Q1 		$3.42K Buy
113,498
+13,498
+13% +$528 ﹤0.01% 206
2023
Q4 		$6K Buy
100,000
+3,832
+4% +$159 ﹤0.01% 165
2023
Q3 		$4.88K Buy
96,168
+36,168
+60% +$2.92K ﹤0.01% 168
2023
Q2 		$3.01K Buy
60,000
+5,000
+9% +$184 ﹤0.01% 174
2023
Q1 		$2.3K Buy
55,000
+4,951
+10% +$327 ﹤0.01% 166
2022
Q4 		$4K Buy
+50,049
New +$3.36K ﹤0.01% 85

Other funds holding ASBPW

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Flow State Investments's ASBPW Position: Q3 2024 in Review

Flow State Investments sold out of Aspire Biopharma Warrant (ASBPW) in Q3 2024, closing a stake of 113,498 shares — an estimated $5.1K sold.

Flow State Investments first reported a position in ASBPW in Q4 2022 and held it in 7 quarters. The position peaked at $6K in Q4 2023. 30 funds tracked by Wall St. Rank hold ASBPW as of Q3 2024.

  • Flow State Investments reported no remaining Aspire Biopharma Warrant position as of Q3 2024 after selling out during the quarter.
  • Flow State Investments sold 113,498 Aspire Biopharma Warrant shares in Q3 2024, an estimated $5.1K.
  • Flow State Investments first reported a position in Aspire Biopharma Warrant in Q4 2022 and held it in 7 quarters.
  • Flow State Investments's Aspire Biopharma Warrant position peaked at $6K in Q4 2023.
  • 30 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q3 2024.

Based on Flow State Investments's 13F filing for Q3 2024, filed 14 Nov 2024.